Compare Moderna, Inc. (MRNA) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while T-Rex 2X Long MSTR Daily Target ETF trades at $2.14. The key difference: Moderna, Inc. is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| MRNA | MSTU | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $81.80 | $92.70 |
52-Week Low | $22.36 | $1.46 |
Enterprise Value | $19.70B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
